Literature DB >> 11276105

Post-radiotherapy contrast enhancement changes in fast dynamic MRI of cervical carcinoma.

E A Boss1, L F Massuger, L A Pop, L C Verhoef, H J Huisman, H Boonstra, J O Barentsz.   

Abstract

This pilot study determines fast dynamic gadolinium enhanced MRI contrast enhancement parameters (onset of enhancement and time to peak enhancement) before and after radiotherapy in 10 cervical carcinoma patients. Before radiotherapy, onset of enhancement and time to peak enhancement were early, with a median of 4.5 and 5.2 seconds, respectively. High-grade tumors showed early enhancement, compared with low-grade. After radiotherapy, contrast enhancement patterns differed. In survivors, onset of enhancement after radiotherapy was later than before radiotherapy. In non-survivors, onset of enhancement after radiotherapy was still early. The median difference in onset of enhancement before and after radiotherapy in survivors and non-survivors was an increase of 3.2 and a decrease of 1.1 seconds, respectively. Early onset of enhancement after radiotherapy was a better predictor for survival than a high-signal intensity zone on post radiotherapy unenhanced T1/T2-weighted MRI. It is concluded that enhancement parameters from fast dynamic Gd-enhanced MR images can provide additional functional information with regard to tumor vascularization, and may have prognostic significance. It complements clinical examination and unenhanced MRI in determining the effectiveness of radiotherapy treatment in cervical carcinoma. Future studies will focus on the clinical utility and improvements of the estimation of contrast-enhanced parameters with this new technique.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11276105     DOI: 10.1002/jmri.1084

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  6 in total

Review 1.  Applications of molecular imaging.

Authors:  Craig J Galbán; Stefanie Galbán; Marcian E Van Dort; Gary D Luker; Mahaveer S Bhojani; Alnawaz Rehemtulla; Brian D Ross
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

2.  Imaging Biomarkers and Liquid Biopsy in Assessment of Cervical Cancer.

Authors:  Mansur A Ghani; Joy Liau; Ramez Eskander; Loren Mell; Tahir Yusufaly; Sebastian Obrzut
Journal:  J Comput Assist Tomogr       Date:  2022-08-16       Impact factor: 2.081

Review 3.  What's New in Imaging for Gynecologic Cancer?

Authors:  Sairah R Khan; Mubarik Arshad; Kathryn Wallitt; Victoria Stewart; Nishat Bharwani; Tara D Barwick
Journal:  Curr Oncol Rep       Date:  2017-11-06       Impact factor: 5.075

Review 4.  Functional imaging to predict tumor response in locally advanced cervical cancer.

Authors:  Tara D Barwick; Alexandra Taylor; Andrea Rockall
Journal:  Curr Oncol Rep       Date:  2013-12       Impact factor: 5.075

Review 5.  Diffusion-weighted imaging and dynamic contrast-enhanced MRI in assessing response and recurrent disease in gynaecological malignancies.

Authors:  Ayshea Hameeduddin; Anju Sahdev
Journal:  Cancer Imaging       Date:  2015-03-15       Impact factor: 3.909

6.  The role of MRI in cervical cancer > 2 cm (FIGO stage IB2-IIA1) conservatively treated with neoadjuvant chemotherapy followed by conization: a pilot study.

Authors:  Luca Russo; Benedetta Gui; Maura Miccò; Camilla Panico; Rosa De Vincenzo; Francesco Fanfani; Giovanni Scambia; Riccardo Manfredi
Journal:  Radiol Med       Date:  2021-05-31       Impact factor: 6.313

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.